Products for Research Use Only
RegisterLogin

Fidasimtamab

CAT: 0804-HY-P99618-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99618-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity[1].
CAS Number
2377419-89-9
Product Name Alternative
IBI-315; BH2950
UNSPSC
12352203
Target
EGFR; PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/fidasimtamab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Fidasimtamab]
Molecular Weight
(144.62 kDa)
References & Citations
[1]Shijie Jin, et al. Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduct Target Ther. 2022 Feb 7;7 (1) :39.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831841-01Fidasimtamab
GTR18337762-01Fidasimtamab Antibody
DHC09614Research Grade Fidasimtamab
E55B1286Fidasimtamab (Reference antibody)
GTR18697309-01Fidasimtamab Human Monoclonal Antibody
A135534Fidasimtamab Biosimilar (Monoclonal, IgG1-kappa)
F1437-1Anti-HER2 & PD-1 Antibody (Fidasimtamab)
PX-TA1764-01Fidasimtamab Biosimilar - Anti-HER2 & PD1 mAb - Research Grade

Popular Products